Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.
Find a Doctor
John Letterio, MD

John Letterio, MD

  • Specialty: Pediatric Hematology and Oncology
    View Expertise
  • Languages Spoken: English

Biography: John Letterio, MD

Expertise

  • Pediatric Hematology
  • Pediatric Oncology

Titles

  • Interim Director, UH Seidman Cancer Center
  • Director, Angie Fowler Adolescent and Young Adult Cancer Institute, University Hospitals
  • Division Chief, Pediatric Hematology and Oncology, UH Cleveland Medical Center
  • Division Chief, Pediatric Hematology and Oncology, UH Rainbow Babies and Children's Hospital
  • Director, UH Angie Fowler Adolescent and Young Adult Cancer Institute, UH Cleveland Medical Center
  • Professor, CWRU School of Medicine
  • Jane and Lee Seidman Chair in Pediatric Cancer Innovation, UH Rainbow Babies & Children's Hospital

Education

Fellowship | Pediatric Hematology/Oncology
Pediatric Hematology/Oncology - National Cancer Institute (Nci) (1990 - 1993)

Residency | Pediatrics
Pediatrics - University Hospitals Of Cleveland (1988 - 1990)

Internship | Pediatrics
Pediatrics - University Hospitals Of Cleveland (1987 - 1988)

Medical Education
The Ohio State University College Of Medicine (1987)

Undergraduate
Allegheny College (1982)

Featured Videos

Watch to find out more about this University Hospitals physician.

Industry Relationships

University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.

UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.

View UH’s policy (PDF) on practitioner-industry relationships.

As of December 31, 2016, John Letterio did not disclose any Outside Relationships with Industry.